APO Research
Talk to an analyst

APO RESEARCH · REPORT

Metabotropic Glutamate Receptor 2

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Metabotropic Glutamate Receptor 2 Market Analysis and Forecast 2026-2032

26 December 2025193 pages

Choose your research edition.

Industry ResearchMetabotropic Glutamate Receptor 2 Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Metabotropic Glutamate Receptor 2 Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Metabotropic Glutamate Receptor 2 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Metabotropic Glutamate Receptor 2 Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Metabotropic Glutamate Receptor 2 Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Metabotropic Glutamate Receptor 2 market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Metabotropic Glutamate Receptor 2 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Metabotropic Glutamate Receptor 2 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Metabotropic Glutamate Receptor 2 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Metabotropic Glutamate Receptor 2 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Metabotropic Glutamate Receptor 2 include Johnson & Johnson, Merck & Co Inc, Eli Lilly and Company, Domain Therapeutics SA, Denovo Biopharma LLC, Bristol-Myers Squibb Company and Addex Therapeutics Ltd, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Metabotropic Glutamate Receptor 2, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Metabotropic Glutamate Receptor 2, also provides the sales of main regions and countries. Of the upcoming market potential for Metabotropic Glutamate Receptor 2, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Metabotropic Glutamate Receptor 2 sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Metabotropic Glutamate Receptor 2 market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Metabotropic Glutamate Receptor 2 sales, projected growth trends, production technology, application and end-user industry.

Metabotropic Glutamate Receptor 2 Segment by Company

Johnson & Johnson

Merck & Co Inc

Eli Lilly and Company

Domain Therapeutics SA

Denovo Biopharma LLC

Bristol-Myers Squibb Company

Addex Therapeutics Ltd

Metabotropic Glutamate Receptor 2 Segment by Type

LY-2607540

JNJ-40411813

DT-2442

BMT-133218

Others

Metabotropic Glutamate Receptor 2 Segment by Application

Depression

Chronic Pain

Schizophrenia

Anxiety Disorders

Others

Metabotropic Glutamate Receptor 2 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Metabotropic Glutamate Receptor 2 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Metabotropic Glutamate Receptor 2 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Metabotropic Glutamate Receptor 2.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Metabotropic Glutamate Receptor 2 in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Metabotropic Glutamate Receptor 2 manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Metabotropic Glutamate Receptor 2 sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Metabotropic Glutamate Receptor 2 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. LY-2607540 Major Manufacturers Table 3. JNJ-40411813 Major Manufacturers Table 4. DT-2442 Major Manufacturers Table 5. BMT-133218 Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global Metabotropic Glutamate Receptor 2 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Depression Major Manufacturers Table 9. Chronic Pain Major Manufacturers Table 10. Schizophrenia Major Manufacturers Table 11. Anxiety Disorders Major Manufacturers Table 12. Others Major Manufacturers Table 13. Metabotropic Glutamate Receptor 2 Industry Trends Table 14. Metabotropic Glutamate Receptor 2 Industry Drivers Table 15. Metabotropic Glutamate Receptor 2 Industry Opportunities and Challenges Table 16. Metabotropic Glutamate Receptor 2 Industry Restraints Table 17. Global Metabotropic Glutamate Receptor 2 Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Metabotropic Glutamate Receptor 2 Revenue by Region (2021-2026) & (US$ Million) Table 19. Global Metabotropic Glutamate Receptor 2 Revenue by Region (2027-2032) & (US$ Million) Table 20. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Region (2021-2026) Table 21. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Region (2027-2032) Table 22. Global Metabotropic Glutamate Receptor 2 Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 23. Global Metabotropic Glutamate Receptor 2 Sales by Region (2021-2026) & (W Units) Table 24. Global Metabotropic Glutamate Receptor 2 Sales by Region (2027-2032) & (W Units) Table 25. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Region (2021-2026) Table 26. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Region (2027-2032) Table 27. Global Metabotropic Glutamate Receptor 2 Revenue by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Manufacturers (2021-2026) Table 29. Global Metabotropic Glutamate Receptor 2 Sales by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Manufacturers (2021-2026) Table 31. Global Metabotropic Glutamate Receptor 2 Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 32. Global Metabotropic Glutamate Receptor 2 Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 33. Global Metabotropic Glutamate Receptor 2 Key Manufacturers Manufacturing Sites & Headquarters Table 34. Global Metabotropic Glutamate Receptor 2 Manufacturers, Product Type & Application Table 35. Global Metabotropic Glutamate Receptor 2 Manufacturers' Establishment Date Table 36. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 37. Global Metabotropic Glutamate Receptor 2 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 38. Global Metabotropic Glutamate Receptor 2 Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Metabotropic Glutamate Receptor 2 Revenue by Type (2021-2026) & (US$ Million) Table 40. Global Metabotropic Glutamate Receptor 2 Revenue by Type (2027-2032) & (US$ Million) Table 41. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Type (2021-2026) Table 42. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Type (2027-2032) Table 43. Global Metabotropic Glutamate Receptor 2 Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 44. Global Metabotropic Glutamate Receptor 2 Sales by Type (2021-2026) & (W Units) Table 45. Global Metabotropic Glutamate Receptor 2 Sales by Type (2027-2032) & (W Units) Table 46. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Type (2021-2026) Table 47. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Type (2027-2032) Table 48. Global Metabotropic Glutamate Receptor 2 Price by Type (2021-2026) & (US$/Unit) Table 49. Global Metabotropic Glutamate Receptor 2 Price by Type (2027-2032) & (US$/Unit) Table 50. Global Metabotropic Glutamate Receptor 2 Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Metabotropic Glutamate Receptor 2 Revenue by Application (2021-2026) & (US$ Million) Table 52. Global Metabotropic Glutamate Receptor 2 Revenue by Application (2027-2032) & (US$ Million) Table 53. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Application (2021-2026) Table 54. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Application (2027-2032) Table 55. Global Metabotropic Glutamate Receptor 2 Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 56. Global Metabotropic Glutamate Receptor 2 Sales by Application (2021-2026) & (W Units) Table 57. Global Metabotropic Glutamate Receptor 2 Sales by Application (2027-2032) & (W Units) Table 58. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Application (2021-2026) Table 59. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Application (2027-2032) Table 60. Global Metabotropic Glutamate Receptor 2 Price by Application (2021-2026) & (US$/Unit) Table 61. Global Metabotropic Glutamate Receptor 2 Price by Application (2027-2032) & (US$/Unit) Table 62. Johnson & Johnson Company Information Table 63. Johnson & Johnson Business Overview Table 64. Johnson & Johnson Metabotropic Glutamate Receptor 2 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Johnson & Johnson Metabotropic Glutamate Receptor 2 Product Portfolio Table 66. Johnson & Johnson Recent Development Table 67. Merck & Co Inc Company Information Table 68. Merck & Co Inc Business Overview Table 69. Merck & Co Inc Metabotropic Glutamate Receptor 2 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Merck & Co Inc Metabotropic Glutamate Receptor 2 Product Portfolio Table 71. Merck & Co Inc Recent Development Table 72. Eli Lilly and Company Company Information Table 73. Eli Lilly and Company Business Overview Table 74. Eli Lilly and Company Metabotropic Glutamate Receptor 2 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Eli Lilly and Company Metabotropic Glutamate Receptor 2 Product Portfolio Table 76. Eli Lilly and Company Recent Development Table 77. Domain Therapeutics SA Company Information Table 78. Domain Therapeutics SA Business Overview Table 79. Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Product Portfolio Table 81. Domain Therapeutics SA Recent Development Table 82. Denovo Biopharma LLC Company Information Table 83. Denovo Biopharma LLC Business Overview Table 84. Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Product Portfolio Table 86. Denovo Biopharma LLC Recent Development Table 87. Bristol-Myers Squibb Company Company Information Table 88. Bristol-Myers Squibb Company Business Overview Table 89. Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Product Portfolio Table 91. Bristol-Myers Squibb Company Recent Development Table 92. Addex Therapeutics Ltd Company Information Table 93. Addex Therapeutics Ltd Business Overview Table 94. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Product Portfolio Table 96. Addex Therapeutics Ltd Recent Development Table 97. North America Metabotropic Glutamate Receptor 2 Revenue by Type (2021-2026) & (US$ Million) Table 98. North America Metabotropic Glutamate Receptor 2 Revenue by Type (2027-2032) & (US$ Million) Table 99. North America Metabotropic Glutamate Receptor 2 Sales by Type (2021-2026) & (W Units) Table 100. North America Metabotropic Glutamate Receptor 2 Sales by Type (2027-2032) & (W Units) Table 101. North America Metabotropic Glutamate Receptor 2 Sales Price by Type (2021-2026) & (US$/Unit) Table 102. North America Metabotropic Glutamate Receptor 2 Sales Price by Type (2027-2032) & (US$/Unit) Table 103. North America Metabotropic Glutamate Receptor 2 Revenue by Application (2021-2026) & (US$ Million) Table 104. North America Metabotropic Glutamate Receptor 2 Revenue by Application (2027-2032) & (US$ Million) Table 105. North America Metabotropic Glutamate Receptor 2 Sales by Application (2021-2026) & (W Units) Table 106. North America Metabotropic Glutamate Receptor 2 Sales by Application (2027-2032) & (W Units) Table 107. North America Metabotropic Glutamate Receptor 2 Sales Price by Application (2021-2026) & (US$/Unit) Table 108. North America Metabotropic Glutamate Receptor 2 Sales Price by Application (2027-2032) & (US$/Unit) Table 109. North America Metabotropic Glutamate Receptor 2 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. North America Metabotropic Glutamate Receptor 2 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 111. North America Metabotropic Glutamate Receptor 2 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 112. North America Metabotropic Glutamate Receptor 2 Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 113. North America Metabotropic Glutamate Receptor 2 Sales by Country (2021-2026) & (W Units) Table 114. North America Metabotropic Glutamate Receptor 2 Sales by Country (2027-2032) & (W Units) Table 115. North America Metabotropic Glutamate Receptor 2 Sales Price by Country (2021-2026) & (US$/Unit) Table 116. North America Metabotropic Glutamate Receptor 2 Sales Price by Country (2027-2032) & (US$/Unit) Table 117. United States Metabotropic Glutamate Receptor 2 Revenue (2021-2032) & (US$ Million) Table 118. Canada Metabotropic Glutamate Receptor 2 Revenue (2021-2032) & (US$ Million) Table 119. Mexico Metabotropic Glutamate Receptor 2 Revenue (2021-2032) & (US$ Million) Table 120. Europe Metabotropic Glutamate Receptor 2 Revenue by Type (2021-2026) & (US$ Million) Table 121. Europe Metabotropic Glutamate Receptor 2 Revenue by Type (2027-2032) & (US$ Million) Table 122. Europe Metabotropic Glutamate Receptor 2 Sales by Type (2021-2026) & (W Units) Table 123. Europe Metabotropic Glutamate Receptor 2 Sales by Type (2027-2032) & (W Units) Table 124. Europe Metabotropic Glutamate Receptor 2 Sales Price by Type (2021-2026) & (US$/Unit) Table 125. Europe Metabotropic Glutamate Receptor 2 Sales Price by Type (2027-2032) & (US$/Unit) Table 126. Europe Metabotropic Glutamate Receptor 2 Revenue by Application (2021-2026) & (US$ Million) Table 127. Europe Metabotropic Glutamate Receptor 2 Revenue by Application (2027-2032) & (US$ Million) Table 128. Europe Metabotropic Glutamate Receptor 2 Sales by Application (2021-2026) & (W Units) Table 129. Europe Metabotropic Glutamate Receptor 2 Sales by Application (2027-2032) & (W Units) Table 130. Europe Metabotropic Glutamate Receptor 2 Sales Price by Application (2021-2026) & (US$/Unit) Table 131. Europe Metabotropic Glutamate Receptor 2 Sales Price by Application (2027-2032) & (US$/Unit) Table 132. Europe Metabotropic Glutamate Receptor 2 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 133. Europe Metabotropic Glutamate Receptor 2 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 134. Europe Metabotropic Glutamate Receptor 2 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 135. Europe Metabotropic Glutamate Receptor 2 Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 136. Europe Metabotropic Glutamate Receptor 2 Sales by Country (2021-2026) & (W Units) Table 137. Europe Metabotropic Glutamate Receptor 2 Sales by Country (2027-2032) & (W Units) Table 138. Europe Metabotropic Glutamate Receptor 2 Sales Price by Country (2021-2026) & (US$/Unit) Table 139. Europe Metabotropic Glutamate Receptor 2 Sales Price by Country (2027-2032) & (US$/Unit) Table 140. Germany Metabotropic Glutamate Receptor 2 Revenue (2021-2032) & (US$ Million) Table 141. France Metabotropic Glutamate Receptor 2 Revenue (2021-2032) & (US$ Million) Table 142. U.K. Metabotropic Glutamate Receptor 2 Revenue (2021-2032) & (US$ Million) Table 143. Italy Metabotropic Glutamate Receptor 2 Revenue (2021-2032) & (US$ Million) Table 144. Russia Metabotropic Glutamate Receptor 2 Revenue (2021-2032) & (US$ Million) Table 145. Spain Metabotropic Glutamate Receptor 2 Revenue (2021-2032) & (US$ Million) Table 146. Netherlands Metabotropic Glutamate Receptor 2 Revenue (2021-2032) & (US$ Million) Table 147. Switzerland Metabotropic Glutamate Receptor 2 Revenue (2021-2032) & (US$ Million) Table 148. Sweden Metabotropic Glutamate Receptor 2 Revenue (2021-2032) & (US$ Million) Table 149. Poland Metabotropic Glutamate Receptor 2 Revenue (2021-2032) & (US$ Million) Table 150. China Metabotropic Glutamate Receptor 2 Revenue by Type (2021-2026) & (US$ Million) Table 151. China Metabotropic Glutamate Receptor 2 Revenue by Type (2027-2032) & (US$ Million) Table 152. China Metabotropic Glutamate Receptor 2 Sales by Type (2021-2026) & (W Units) Table 153. China Metabotropic Glutamate Receptor 2 Sales by Type (2027-2032) & (W Units) Table 154. China Metabotropic Glutamate Receptor 2 Sales Price by Type (2021-2026) & (US$/Unit) Table 155. China Metabotropic Glutamate Receptor 2 Sales Price by Type (2027-2032) & (US$/Unit) Table 156. China Metabotropic Glutamate Receptor 2 Revenue by Application (2021-2026) & (US$ Million) Table 157. China Metabotropic Glutamate Receptor 2 Revenue by Application (2027-2032) & (US$ Million) Table 158. China Metabotropic Glutamate Receptor 2 Sales by Application (2021-2026) & (W Units) Table 159. China Metabotropic Glutamate Receptor 2 Sales by Application (2027-2032) & (W Units) Table 160. China Metabotropic Glutamate Receptor 2 Sales Price by Application (2021-2026) & (US$/Unit) Table 161. China Metabotropic Glutamate Receptor 2 Sales Price by Application (2027-2032) & (US$/Unit) Table 162. Asia Metabotropic Glutamate Receptor 2 Revenue by Type (2021-2026) & (US$ Million) Table 163. Asia Metabotropic Glutamate Receptor 2 Revenue by Type (2027-2032) & (US$ Million) Table 164. Asia Metabotropic Glutamate Receptor 2 Sales by Type (2021-2026) & (W Units) Table 165. Asia Metabotropic Glutamate Receptor 2 Sales by Type (2027-2032) & (W Units) Table 166. Asia Metabotropic Glutamate Receptor 2 Sales Price by Type (2021-2026) & (US$/Unit) Table 167. Asia Metabotropic Glutamate Receptor 2 Sales Price by Type (2027-2032) & (US$/Unit) Table 168. Asia Metabotropic Glutamate Receptor 2 Revenue by Application (2021-2026) & (US$ Million) Table 169. Asia Metabotropic Glutamate Receptor 2 Revenue by Application (2027-2032) & (US$ Million) Table 170. Asia Metabotropic Glutamate Receptor 2 Sales by Application (2021-2026) & (W Units) Table 171. Asia Metabotropic Glutamate Receptor 2 Sales by Application (2027-2032) & (W Units) Table 172. Asia Metabotropic Glutamate Receptor 2 Sales Price by Application (2021-2026) & (US$/Unit) Table 173. Asia Metabotropic Glutamate Receptor 2 Sales Price by Application (2027-2032) & (US$/Unit) Table 174. Asia Metabotropic Glutamate Receptor 2 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 175. Asia Metabotropic Glutamate Receptor 2 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 176. Asia Metabotropic Glutamate Receptor 2 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 177. Asia Metabotropic Glutamate Receptor 2 Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 178. Asia Metabotropic Glutamate Receptor 2 Sales by Country (2021-2026) & (W Units) Table 179. Asia Metabotropic Glutamate Receptor 2 Sales by Country (2027-2032) & (W Units) Table 180. Asia Metabotropic Glutamate Receptor 2 Sales Price by Country (2021-2026) & (US$/Unit) Table 181. Asia Metabotropic Glutamate Receptor 2 Sales Price by Country (2027-2032) & (US$/Unit) Table 182. Japan Metabotropic Glutamate Receptor 2 Revenue (2021-2032) & (US$ Million) Table 183. South Korea Metabotropic Glutamate Receptor 2 Revenue (2021-2032) & (US$ Million) Table 184. India Metabotropic Glutamate Receptor 2 Revenue (2021-2032) & (US$ Million) Table 185. Australia Metabotropic Glutamate Receptor 2 Revenue (2021-2032) & (US$ Million) Table 186. Taiwan Metabotropic Glutamate Receptor 2 Revenue (2021-2032) & (US$ Million) Table 187. Southeast Asia Metabotropic Glutamate Receptor 2 Revenue (2021-2032) & (US$ Million) Table 188. SAMEA Metabotropic Glutamate Receptor 2 Revenue by Type (2021-2026) & (US$ Million) Table 189. SAMEA Metabotropic Glutamate Receptor 2 Revenue by Type (2027-2032) & (US$ Million) Table 190. SAMEA Metabotropic Glutamate Receptor 2 Sales by Type (2021-2026) & (W Units) Table 191. SAMEA Metabotropic Glutamate Receptor 2 Sales by Type (2027-2032) & (W Units) Table 192. SAMEA Metabotropic Glutamate Receptor 2 Sales Price by Type (2021-2026) & (US$/Unit) Table 193. SAMEA Metabotropic Glutamate Receptor 2 Sales Price by Type (2027-2032) & (US$/Unit) Table 194. SAMEA Metabotropic Glutamate Receptor 2 Revenue by Application (2021-2026) & (US$ Million) Table 195. SAMEA Metabotropic Glutamate Receptor 2 Revenue by Application (2027-2032) & (US$ Million) Table 196. SAMEA Metabotropic Glutamate Receptor 2 Sales by Application (2021-2026) & (W Units) Table 197. SAMEA Metabotropic Glutamate Receptor 2 Sales by Application (2027-2032) & (W Units) Table 198. SAMEA Metabotropic Glutamate Receptor 2 Sales Price by Application (2021-2026) & (US$/Unit) Table 199. SAMEA Metabotropic Glutamate Receptor 2 Sales Price by Application (2027-2032) & (US$/Unit) Table 200. SAMEA Metabotropic Glutamate Receptor 2 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 201. SAMEA Metabotropic Glutamate Receptor 2 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 202. SAMEA Metabotropic Glutamate Receptor 2 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 203. SAMEA Metabotropic Glutamate Receptor 2 Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 204. SAMEA Metabotropic Glutamate Receptor 2 Sales by Country (2021-2026) & (W Units) Table 205. SAMEA Metabotropic Glutamate Receptor 2 Sales by Country (2027-2032) & (W Units) Table 206. SAMEA Metabotropic Glutamate Receptor 2 Sales Price by Country (2021-2026) & (US$/Unit) Table 207. SAMEA Metabotropic Glutamate Receptor 2 Sales Price by Country (2027-2032) & (US$/Unit) Table 208. Brazil Metabotropic Glutamate Receptor 2 Revenue (2021-2032) & (US$ Million) Table 209. Argentina Metabotropic Glutamate Receptor 2 Revenue (2021-2032) & (US$ Million) Table 210. Chile Metabotropic Glutamate Receptor 2 Revenue (2021-2032) & (US$ Million) Table 211. Colombia Metabotropic Glutamate Receptor 2 Revenue (2021-2032) & (US$ Million) Table 212. Peru Metabotropic Glutamate Receptor 2 Revenue (2021-2032) & (US$ Million) Table 213. Saudi Arabia Metabotropic Glutamate Receptor 2 Revenue (2021-2032) & (US$ Million) Table 214. Israel Metabotropic Glutamate Receptor 2 Revenue (2021-2032) & (US$ Million) Table 215. UAE Metabotropic Glutamate Receptor 2 Revenue (2021-2032) & (US$ Million) Table 216. Turkey Metabotropic Glutamate Receptor 2 Revenue (2021-2032) & (US$ Million) Table 217. Iran Metabotropic Glutamate Receptor 2 Revenue (2021-2032) & (US$ Million) Table 218. Egypt Metabotropic Glutamate Receptor 2 Revenue (2021-2032) & (US$ Million) Table 219. Key Raw Materials Table 220. Raw Materials Key Suppliers Table 221. Metabotropic Glutamate Receptor 2 Distributors List Table 222. Metabotropic Glutamate Receptor 2 Customers List Table 223. Research Programs/Design for This Report Table 224. Authors List of This Report Table 225. Secondary Sources Table 226. Primary Sources List of Figures Figure 1. Metabotropic Glutamate Receptor 2 Image Figure 2. Global Metabotropic Glutamate Receptor 2 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Metabotropic Glutamate Receptor 2 Market Size Share 2021 VS 2025 VS 2032 Figure 4. LY-2607540 Image Figure 5. JNJ-40411813 Image Figure 6. DT-2442 Image Figure 7. BMT-133218 Image Figure 8. Others Image Figure 9. Global Metabotropic Glutamate Receptor 2 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Metabotropic Glutamate Receptor 2 Market Size Share 2021 VS 2025 VS 2032 Figure 11. Depression Image Figure 12. Chronic Pain Image Figure 13. Schizophrenia Image Figure 14. Anxiety Disorders Image Figure 15. Others Image Figure 16. Global Metabotropic Glutamate Receptor 2 Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Metabotropic Glutamate Receptor 2 Revenue (2021-2032) & (US$ Million) Figure 18. Global Metabotropic Glutamate Receptor 2 Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Region: 2025 Versus 2032 Figure 20. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Region (2021-2032) Figure 21. Global Metabotropic Glutamate Receptor 2 Sales (2021-2032) & (W Units) Figure 22. Global Metabotropic Glutamate Receptor 2 Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 23. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Region (2021-2032) Figure 24. US & Canada & Mexico Metabotropic Glutamate Receptor 2 Sales YoY (2021-2032) & (W Units) Figure 25. Europe Metabotropic Glutamate Receptor 2 Sales YoY (2021-2032) & (W Units) Figure 26. China Metabotropic Glutamate Receptor 2 Sales YoY (2021-2032) & (W Units) Figure 27. Asia (Excluding China) Metabotropic Glutamate Receptor 2 Sales YoY (2021-2032) & (W Units) Figure 28. South America, Middle East and Africa Metabotropic Glutamate Receptor 2 Sales YoY (2021-2032) & (W Units) Figure 29. Global Metabotropic Glutamate Receptor 2 Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 30. Global Metabotropic Glutamate Receptor 2 Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 31. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 32. Global Metabotropic Glutamate Receptor 2 Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Type (2021-2032) Figure 35. Global Metabotropic Glutamate Receptor 2 Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 36. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 37. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Type (2021-2032) Figure 38. Global Metabotropic Glutamate Receptor 2 Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 39. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Application (2021-2032) Figure 41. Global Metabotropic Glutamate Receptor 2 Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 42. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 43. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Application (2021-2032) Figure 44. North America Metabotropic Glutamate Receptor 2 Revenue Share by Type (2021-2032) Figure 45. North America Metabotropic Glutamate Receptor 2 Sales Share by Type (2021-2032) Figure 46. North America Metabotropic Glutamate Receptor 2 Revenue Share by Application (2021-2032) Figure 47. North America Metabotropic Glutamate Receptor 2 Sales Share by Application (2021-2032) Figure 48. North America Metabotropic Glutamate Receptor 2 Revenue Share by Country (2021-2032) Figure 49. North America Metabotropic Glutamate Receptor 2 Sales Share by Country (2021-2032) Figure 50. Europe Metabotropic Glutamate Receptor 2 Revenue Share by Type (2021-2032) Figure 51. Europe Metabotropic Glutamate Receptor 2 Sales Share by Type (2021-2032) Figure 52. Europe Metabotropic Glutamate Receptor 2 Revenue Share by Application (2021-2032) Figure 53. Europe Metabotropic Glutamate Receptor 2 Sales Share by Application (2021-2032) Figure 54. Europe Metabotropic Glutamate Receptor 2 Revenue Share by Country (2021-2032) Figure 55. Europe Metabotropic Glutamate Receptor 2 Sales Share by Country (2021-2032) Figure 56. China Metabotropic Glutamate Receptor 2 Revenue Share by Type (2021-2032) Figure 57. China Metabotropic Glutamate Receptor 2 Sales Share by Type (2021-2032) Figure 58. China Metabotropic Glutamate Receptor 2 Revenue Share by Application (2021-2032) Figure 59. China Metabotropic Glutamate Receptor 2 Sales Share by Application (2021-2032) Figure 60. Asia Metabotropic Glutamate Receptor 2 Revenue Share by Type (2021-2032) Figure 61. Asia Metabotropic Glutamate Receptor 2 Sales Share by Type (2021-2032) Figure 62. Asia Metabotropic Glutamate Receptor 2 Revenue Share by Application (2021-2032) Figure 63. Asia Metabotropic Glutamate Receptor 2 Sales Share by Application (2021-2032) Figure 64. Asia Metabotropic Glutamate Receptor 2 Revenue Share by Country (2021-2032) Figure 65. Asia Metabotropic Glutamate Receptor 2 Sales Share by Country (2021-2032) Figure 66. SAMEA Metabotropic Glutamate Receptor 2 Revenue Share by Type (2021-2032) Figure 67. SAMEA Metabotropic Glutamate Receptor 2 Sales Share by Type (2021-2032) Figure 68. SAMEA Metabotropic Glutamate Receptor 2 Revenue Share by Application (2021-2032) Figure 69. SAMEA Metabotropic Glutamate Receptor 2 Sales Share by Application (2021-2032) Figure 70. SAMEA Metabotropic Glutamate Receptor 2 Revenue Share by Country (2021-2032) Figure 71. SAMEA Metabotropic Glutamate Receptor 2 Sales Share by Country (2021-2032) Figure 72. Metabotropic Glutamate Receptor 2 Value Chain Figure 73. Manufacturing Cost Structure Figure 74. Metabotropic Glutamate Receptor 2 Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • LY-2607540
  • JNJ-40411813
  • DT-2442
  • BMT-133218
  • Others
Applications
  • Depression
  • Chronic Pain
  • Schizophrenia
  • Anxiety Disorders
  • Others
Companies covered
  • Johnson & Johnson
  • Merck & Co Inc
  • Eli Lilly and Company
  • Domain Therapeutics SA
  • Denovo Biopharma LLC
  • Bristol-Myers Squibb Company
  • Addex Therapeutics Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Metabotropic Glutamate Receptor 2 Market by Type
  3. 1.2.1 Global Metabotropic Glutamate Receptor 2 Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 LY-2607540
  5. 1.2.3 JNJ-40411813
  6. 1.2.4 DT-2442
  7. 1.2.5 BMT-133218
  8. 1.2.6 Others
  9. 1.3 Metabotropic Glutamate Receptor 2 Market by Application
  10. 1.3.1 Global Metabotropic Glutamate Receptor 2 Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Depression
  12. 1.3.3 Chronic Pain
  13. 1.3.4 Schizophrenia
  14. 1.3.5 Anxiety Disorders
  15. 1.3.6 Others
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Metabotropic Glutamate Receptor 2 Market Dynamics
  1. 2.1 Metabotropic Glutamate Receptor 2 Industry Trends
  2. 2.2 Metabotropic Glutamate Receptor 2 Industry Drivers
  3. 2.3 Metabotropic Glutamate Receptor 2 Industry Opportunities and Challenges
  4. 2.4 Metabotropic Glutamate Receptor 2 Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Metabotropic Glutamate Receptor 2 Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Metabotropic Glutamate Receptor 2 Revenue by Region
  3. 3.2.1 Global Metabotropic Glutamate Receptor 2 Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Metabotropic Glutamate Receptor 2 Revenue by Region (2021-2026)
  5. 3.2.3 Global Metabotropic Glutamate Receptor 2 Revenue by Region (2027-2032)
  6. 3.2.4 Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Metabotropic Glutamate Receptor 2 Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Metabotropic Glutamate Receptor 2 Sales by Region
  9. 3.4.1 Global Metabotropic Glutamate Receptor 2 Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Metabotropic Glutamate Receptor 2 Sales by Region (2021-2026)
  11. 3.4.3 Global Metabotropic Glutamate Receptor 2 Sales by Region (2027-2032)
  12. 3.4.4 Global Metabotropic Glutamate Receptor 2 Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Metabotropic Glutamate Receptor 2 Revenue by Manufacturers
  2. 4.1.1 Global Metabotropic Glutamate Receptor 2 Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Metabotropic Glutamate Receptor 2 Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Metabotropic Glutamate Receptor 2 Sales by Manufacturers
  6. 4.2.1 Global Metabotropic Glutamate Receptor 2 Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Metabotropic Glutamate Receptor 2 Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Metabotropic Glutamate Receptor 2 Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Metabotropic Glutamate Receptor 2 Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Metabotropic Glutamate Receptor 2 Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Metabotropic Glutamate Receptor 2 Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Metabotropic Glutamate Receptor 2 Manufacturers, Product Type & Application
  13. 4.7 Global Metabotropic Glutamate Receptor 2 Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Metabotropic Glutamate Receptor 2 Market CR5 and HHI
  16. 4.8.2 2025 Metabotropic Glutamate Receptor 2 Tier 1, Tier 2, and Tier 3
5 Metabotropic Glutamate Receptor 2 Market by Type
  1. 5.1 Global Metabotropic Glutamate Receptor 2 Revenue by Type
  2. 5.1.1 Global Metabotropic Glutamate Receptor 2 Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Metabotropic Glutamate Receptor 2 Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Metabotropic Glutamate Receptor 2 Sales by Type
  6. 5.2.1 Global Metabotropic Glutamate Receptor 2 Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Metabotropic Glutamate Receptor 2 Sales by Type (2021-2032) & (W Units)
  8. 5.2.3 Global Metabotropic Glutamate Receptor 2 Sales Market Share by Type (2021-2032)
  9. 5.3 Global Metabotropic Glutamate Receptor 2 Price by Type
6 Metabotropic Glutamate Receptor 2 Market by Application
  1. 6.1 Global Metabotropic Glutamate Receptor 2 Revenue by Application
  2. 6.1.1 Global Metabotropic Glutamate Receptor 2 Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Metabotropic Glutamate Receptor 2 Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Metabotropic Glutamate Receptor 2 Sales by Application
  6. 6.2.1 Global Metabotropic Glutamate Receptor 2 Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Metabotropic Glutamate Receptor 2 Sales by Application (2021-2032) & (W Units)
  8. 6.2.3 Global Metabotropic Glutamate Receptor 2 Sales Market Share by Application (2021-2032)
  9. 6.3 Global Metabotropic Glutamate Receptor 2 Price by Application
7 Company Profiles
  1. 7.1 Johnson & Johnson
  2. 7.1.1 Johnson & Johnson Company Information
  3. 7.1.2 Johnson & Johnson Business Overview
  4. 7.1.3 Johnson & Johnson Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Johnson & Johnson Metabotropic Glutamate Receptor 2 Product Portfolio
  6. 7.1.5 Johnson & Johnson Recent Developments
  7. 7.2 Merck & Co Inc
  8. 7.2.1 Merck & Co Inc Company Information
  9. 7.2.2 Merck & Co Inc Business Overview
  10. 7.2.3 Merck & Co Inc Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Merck & Co Inc Metabotropic Glutamate Receptor 2 Product Portfolio
  12. 7.2.5 Merck & Co Inc Recent Developments
  13. 7.3 Eli Lilly and Company
  14. 7.3.1 Eli Lilly and Company Company Information
  15. 7.3.2 Eli Lilly and Company Business Overview
  16. 7.3.3 Eli Lilly and Company Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Eli Lilly and Company Metabotropic Glutamate Receptor 2 Product Portfolio
  18. 7.3.5 Eli Lilly and Company Recent Developments
  19. 7.4 Domain Therapeutics SA
  20. 7.4.1 Domain Therapeutics SA Company Information
  21. 7.4.2 Domain Therapeutics SA Business Overview
  22. 7.4.3 Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Product Portfolio
  24. 7.4.5 Domain Therapeutics SA Recent Developments
  25. 7.5 Denovo Biopharma LLC
  26. 7.5.1 Denovo Biopharma LLC Company Information
  27. 7.5.2 Denovo Biopharma LLC Business Overview
  28. 7.5.3 Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Product Portfolio
  30. 7.5.5 Denovo Biopharma LLC Recent Developments
  31. 7.6 Bristol-Myers Squibb Company
  32. 7.6.1 Bristol-Myers Squibb Company Company Information
  33. 7.6.2 Bristol-Myers Squibb Company Business Overview
  34. 7.6.3 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Product Portfolio
  36. 7.6.5 Bristol-Myers Squibb Company Recent Developments
  37. 7.7 Addex Therapeutics Ltd
  38. 7.7.1 Addex Therapeutics Ltd Company Information
  39. 7.7.2 Addex Therapeutics Ltd Business Overview
  40. 7.7.3 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Product Portfolio
  42. 7.7.5 Addex Therapeutics Ltd Recent Developments
8 North America
  1. 8.1 North America Metabotropic Glutamate Receptor 2 Market Size by Type
  2. 8.1.1 North America Metabotropic Glutamate Receptor 2 Revenue by Type (2021-2032)
  3. 8.1.2 North America Metabotropic Glutamate Receptor 2 Sales by Type (2021-2032)
  4. 8.1.3 North America Metabotropic Glutamate Receptor 2 Price by Type (2021-2032)
  5. 8.2 North America Metabotropic Glutamate Receptor 2 Market Size by Application
  6. 8.2.1 North America Metabotropic Glutamate Receptor 2 Revenue by Application (2021-2032)
  7. 8.2.2 North America Metabotropic Glutamate Receptor 2 Sales by Application (2021-2032)
  8. 8.2.3 North America Metabotropic Glutamate Receptor 2 Price by Application (2021-2032)
  9. 8.3 North America Metabotropic Glutamate Receptor 2 Market Size by Country
  10. 8.3.1 North America Metabotropic Glutamate Receptor 2 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Metabotropic Glutamate Receptor 2 Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Metabotropic Glutamate Receptor 2 Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Metabotropic Glutamate Receptor 2 Market Size by Type
  2. 9.1.1 Europe Metabotropic Glutamate Receptor 2 Revenue by Type (2021-2032)
  3. 9.1.2 Europe Metabotropic Glutamate Receptor 2 Sales by Type (2021-2032)
  4. 9.1.3 Europe Metabotropic Glutamate Receptor 2 Price by Type (2021-2032)
  5. 9.2 Europe Metabotropic Glutamate Receptor 2 Market Size by Application
  6. 9.2.1 Europe Metabotropic Glutamate Receptor 2 Revenue by Application (2021-2032)
  7. 9.2.2 Europe Metabotropic Glutamate Receptor 2 Sales by Application (2021-2032)
  8. 9.2.3 Europe Metabotropic Glutamate Receptor 2 Price by Application (2021-2032)
  9. 9.3 Europe Metabotropic Glutamate Receptor 2 Market Size by Country
  10. 9.3.1 Europe Metabotropic Glutamate Receptor 2 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Metabotropic Glutamate Receptor 2 Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Metabotropic Glutamate Receptor 2 Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Metabotropic Glutamate Receptor 2 Market Size by Type
  2. 10.1.1 China Metabotropic Glutamate Receptor 2 Revenue by Type (2021-2032)
  3. 10.1.2 China Metabotropic Glutamate Receptor 2 Sales by Type (2021-2032)
  4. 10.1.3 China Metabotropic Glutamate Receptor 2 Price by Type (2021-2032)
  5. 10.2 China Metabotropic Glutamate Receptor 2 Market Size by Application
  6. 10.2.1 China Metabotropic Glutamate Receptor 2 Revenue by Application (2021-2032)
  7. 10.2.2 China Metabotropic Glutamate Receptor 2 Sales by Application (2021-2032)
  8. 10.2.3 China Metabotropic Glutamate Receptor 2 Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Metabotropic Glutamate Receptor 2 Market Size by Type
  2. 11.1.1 Asia Metabotropic Glutamate Receptor 2 Revenue by Type (2021-2032)
  3. 11.1.2 Asia Metabotropic Glutamate Receptor 2 Sales by Type (2021-2032)
  4. 11.1.3 Asia Metabotropic Glutamate Receptor 2 Price by Type (2021-2032)
  5. 11.2 Asia Metabotropic Glutamate Receptor 2 Market Size by Application
  6. 11.2.1 Asia Metabotropic Glutamate Receptor 2 Revenue by Application (2021-2032)
  7. 11.2.2 Asia Metabotropic Glutamate Receptor 2 Sales by Application (2021-2032)
  8. 11.2.3 Asia Metabotropic Glutamate Receptor 2 Price by Application (2021-2032)
  9. 11.3 Asia Metabotropic Glutamate Receptor 2 Market Size by Country
  10. 11.3.1 Asia Metabotropic Glutamate Receptor 2 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Metabotropic Glutamate Receptor 2 Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Metabotropic Glutamate Receptor 2 Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Metabotropic Glutamate Receptor 2 Market Size by Type
  2. 12.1.1 SAMEA Metabotropic Glutamate Receptor 2 Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Metabotropic Glutamate Receptor 2 Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Metabotropic Glutamate Receptor 2 Price by Type (2021-2032)
  5. 12.2 SAMEA Metabotropic Glutamate Receptor 2 Market Size by Application
  6. 12.2.1 SAMEA Metabotropic Glutamate Receptor 2 Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Metabotropic Glutamate Receptor 2 Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Metabotropic Glutamate Receptor 2 Price by Application (2021-2032)
  9. 12.3 SAMEA Metabotropic Glutamate Receptor 2 Market Size by Country
  10. 12.3.1 SAMEA Metabotropic Glutamate Receptor 2 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Metabotropic Glutamate Receptor 2 Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Metabotropic Glutamate Receptor 2 Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Metabotropic Glutamate Receptor 2 Value Chain Analysis
  2. 13.1.1 Metabotropic Glutamate Receptor 2 Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Metabotropic Glutamate Receptor 2 Production Mode & Process
  6. 13.2 Metabotropic Glutamate Receptor 2 Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Metabotropic Glutamate Receptor 2 Distributors
  9. 13.2.3 Metabotropic Glutamate Receptor 2 Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst